154 related articles for article (PubMed ID: 36224483)
1. Adenocarcinoma of the stomach and esophagogastric junction with low DNA methylation show poor prognoses.
Urabe M; Matsusaka K; Ushiku T; Fukuyo M; Rahmutulla B; Yamashita H; Seto Y; Fukayama M; Kaneda A
Gastric Cancer; 2023 Jan; 26(1):95-107. PubMed ID: 36224483
[TBL] [Abstract][Full Text] [Related]
2. Association of frequent hypermethylation with high grade histological subtype in lung adenocarcinoma.
Ito Y; Usui G; Seki M; Fukuyo M; Matsusaka K; Hoshii T; Sata Y; Morimoto J; Hata A; Nakajima T; Rahmutulla B; Kaiho T; Inage T; Tanaka K; Sakairi Y; Suzuki H; Yoshino I; Kaneda A
Cancer Sci; 2023 Jul; 114(7):3003-3013. PubMed ID: 37082886
[TBL] [Abstract][Full Text] [Related]
3. Different histological status of gastritis in superficial adenocarcinoma of the esophagogastric junction.
Yamada M; Kushima R; Oda I; Mojtahed K; Nonaka S; Suzuki H; Yoshinaga S; Matsubara A; Taniguchi H; Sekine S; Saito Y; Shimoda T
Jpn J Clin Oncol; 2014 Jan; 44(1):65-71. PubMed ID: 24220802
[TBL] [Abstract][Full Text] [Related]
4. Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation.
Zhang CD; Takeshima H; Sekine S; Yamashita S; Liu YY; Hattori N; Abe H; Yamashita H; Fukuda M; Imamura Y; Ushiku T; Katai H; Makino H; Watanabe M; Seto Y; Ushijima T
Gastric Cancer; 2022 Mar; 25(2):336-345. PubMed ID: 34557982
[TBL] [Abstract][Full Text] [Related]
5. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
Hu X; Wu L; Liu B; Chen K
Front Immunol; 2021; 12():651056. PubMed ID: 34122409
[TBL] [Abstract][Full Text] [Related]
6. Changing pattern of adenocarcinoma of the esophagogastric junction in recent 10 years: experience at a large tertiary medical center in China.
Wang K; Yang CQ; Duan LP; Yang XS; Xia ZW; Cui RL; Jin Z; McNutt M
Tumori; 2012; 98(5):568-74. PubMed ID: 23235750
[TBL] [Abstract][Full Text] [Related]
7. Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction.
Reynolds JV; Ravi N; Muldoon C; Larkin JO; Rowley S; O'Byrne K; Hollywood D; O'Toole D
World J Surg; 2010 Dec; 34(12):2821-9. PubMed ID: 20827475
[TBL] [Abstract][Full Text] [Related]
8. The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis.
Takane K; Fukuyo M; Matsusaka K; Ota S; Rahmutulla B; Matsushita K; Miyauchi H; Nakatani Y; Matsubara H; Kaneda A
Oncotarget; 2018 Aug; 9(66):32653-32666. PubMed ID: 30220972
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.
Urabe M; Ushiku T; Shinozaki-Ushiku A; Iwasaki A; Yamazawa S; Yamashita H; Seto Y; Fukayama M
Cancer Med; 2018 Oct; 7(10):5145-5154. PubMed ID: 30239168
[TBL] [Abstract][Full Text] [Related]
10. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.
Liu K; Feng F; Chen XZ; Zhou XY; Zhang JY; Chen XL; Zhang WH; Yang K; Zhang B; Zhang HW; Zhou ZG; Hu JK
Gastric Cancer; 2019 May; 22(3):506-517. PubMed ID: 30390154
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
Urabe M; Yamashita H; Watanabe T; Seto Y
World J Surg; 2018 Jan; 42(1):185-194. PubMed ID: 28741195
[TBL] [Abstract][Full Text] [Related]
13. A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.
Blank S; Rachakonda S; Keller G; Weichert W; Lordick F; Langer R; Springfeld C; Bruckner T; Becker K; Kumar R; Ott K
BMC Cancer; 2014 Feb; 14():58. PubMed ID: 24490800
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas.
Karstens KF; Ghadban T; Sawez S; Konczalla L; Woestemeier A; Bachmann K; Uzunoglu FG; Tachezy M; Vettorazzi E; Izbicki JR; Reeh M
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):638-643. PubMed ID: 31879051
[TBL] [Abstract][Full Text] [Related]
15. [Carcinoma of the oesophagogastric junction and Barrett's esophagus: an almost clear oncologic model?].
Stein HJ; von Rahden BH; Höfler H; Siewert JR
Chirurg; 2003 Aug; 74(8):703-8. PubMed ID: 12928790
[TBL] [Abstract][Full Text] [Related]
16. Two distinct types of cancer of different origin may be mixed in gastroesophageal junction adenocarcinomas in Japan: evidence from direct evaluation of gastric acid secretion.
Horii T; Koike T; Abe Y; Kikuchi R; Unakami H; Iijima K; Imatani A; Ohara S; Shimosegawa T
Scand J Gastroenterol; 2011 Jun; 46(6):710-9. PubMed ID: 21446884
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.
von Rahden BH; Stein HJ; Feith M; Becker K; Siewert JR
J Clin Oncol; 2005 Feb; 23(4):874-9. PubMed ID: 15681533
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with gastroesophageal junction adenocarcinoma in Japan.
Koike T; Ohara S; Inomata Y; Abe Y; Iijima K; Shimosegawa T
Inflammopharmacology; 2007 Apr; 15(2):61-4. PubMed ID: 17450443
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic gastric mucosal atrophy distinguishes the characteristics of superficial esophagogastric junction adenocarcinoma.
Uedo N; Yoshio T; Yoshinaga S; Takeuchi M; Hatta W; Yano T; Tanuma T; Goto O; Takahashi A; Tong D; Lee YY; Nakayama Y; Ichihara S; Gotoda T
Dig Endosc; 2017 Apr; 29 Suppl 2():26-36. PubMed ID: 28425653
[TBL] [Abstract][Full Text] [Related]
20. Navigating the complexities of developing a classification of esophagogastric junction tumors suitable for preoperative setting.
Lochman P
Bratisl Lek Listy; 2024; 125(2):96-101. PubMed ID: 38219062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]